ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for default 登録して無料でリアルタイムの株価、インタラクティブチャート、ライブオプションフローなどを入手してください。

STOK Stoke Therapeutics Inc

14.03
-0.10 (-0.71%)
取引時間後
最終更新日: 05:40:23
15分遅延
名称 銘柄コード 市場 種別
Stoke Therapeutics Inc STOK NASDAQ 普通株式
  前日比 前日比 % 現在値 時刻
-0.10 -0.71% 14.03 05:40:23
始値 安値 高値 終値 前日終値
14.15 13.91 14.39 14.03 14.13
この銘柄の詳細情報 »

最新ニュース

日付 時間 ソース タイトル
2024/5/0705:05EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/5/0620:05EDGAR2Form 8-K - Current report
2024/5/0620:00BWStoke Therapeutics Reports First Quarter Financial Results..
2024/4/2921:00BWStoke Therapeutics Appoints Thomas Leggett as Chief..
2024/4/1721:00BWStoke Therapeutics Appoints Jason Hoitt as Chief Commercial..
2024/4/0505:30BWStoke Therapeutics to Present at the 23rd Annual Needham..
2024/3/2812:40BWStoke Therapeutics Announces Pricing of Upsized $125 Million..
2024/3/2705:07BWStoke Therapeutics Announces Proposed Public Offering
2024/3/2605:01BWStoke Therapeutics Announces Landmark New Data That Support..
2024/3/0606:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/3/0206:28EDGAR2Form 144 - Report of proposed sale of securities
2024/2/2700:38EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2024/2/2700:36EDGAR2Form SC 13G - Statement of acquisition of beneficial..
2024/2/1423:20EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2024/2/0606:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/0206:49EDGAR2Form 144 - Report of proposed sale of securities
2024/1/1806:30BWStoke Therapeutics Announces Inducement Grants Under Nasdaq..
2024/1/0822:09EDGAR2Form 8-K - Current report
2024/1/0822:00BWStoke Therapeutics Highlights Strategic Priorities and..
2024/1/0506:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/0506:30BWStoke Therapeutics to Present at the 42nd Annual J.P. Morgan..
2024/1/0306:29EDGAR2Form 144 - Report of proposed sale of securities
2023/12/1506:05EDGAR2Form 8-K - Current report
2023/12/0606:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/12/0606:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/12/0606:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/12/0606:08EDGAR2Form SC TO-I/A - Tender offer statement by Issuer: [Amend]
2023/12/0123:04EDGAR2Form 8-K - Current report
2023/12/0123:00BWStoke Therapeutics Presents Data From Multiple Studies of..
2023/11/2122:00BWStoke Therapeutics to Present Data from the Company’s Dravet..
2023/11/1806:37EDGAR2Form SC TO-I/A - Tender offer statement by Issuer: [Amend]
2023/11/1006:28EDGAR2Form SC TO-I/A - Tender offer statement by Issuer: [Amend]
2023/11/0806:05EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/0721:05EDGAR2Form 8-K - Current report
2023/11/0721:00BWStoke Therapeutics Reports Third Quarter Financial Results..
2023/11/0706:55EDGAR2Form SC 13G - Statement of acquisition of beneficial..
2023/11/0222:01EDGAR2Form SC TO-I - Tender offer statement by Issuer
2023/10/2706:00EDGAR2Form 8-K - Current report
2023/10/1805:30BWStoke Therapeutics Announces Inducement Grants Under Nasdaq..
2023/9/2905:05EDGAR2Form DEF 14A - Other definitive proxy statements
2023/9/2121:00BWStoke Therapeutics to Participate in the 2023 Cantor Global..
2023/9/2105:37EDGAR2Form 8-K - Current report
2023/9/2105:30BWStoke Therapeutics Appoints Ian Smith to its Board of..
2023/9/1905:05EDGAR2Form PRE 14A - Other preliminary proxy statements
2023/9/0520:00BWStoke Therapeutics Presents Data Related to the Ongoing..
2023/8/0805:06EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/8/0720:05EDGAR2Form 8-K - Current report
2023/8/0720:00BWStoke Therapeutics Reports Second Quarter Financial Results..
2023/8/0221:00BWStoke Therapeutics to Present at the Canaccord Genuity 43rd..
2023/7/2520:05EDGAR2Form 8-K - Current report

最近閲覧した銘柄

Delayed Upgrade Clock